Ovarian cancer patients given fresh hope thanks to double drug treatment

Ruth Joy (pictured), from West Sussex, was diagnosed with advanced, slow-growing ovarian cancer in 2006. She has benefitted from a clinical trial involving MEK inhibitors and defactinib.

Related Keywords

United Kingdom ,West Sussex ,Susana Banerjee ,Institute Of Cancer Research ,Ruth Joy ,Royal Marsden ,Dailymail ,Health ,